Editas Medicine: Resetting Pipeline Just To Be Second To Market Again
Editas Medicine Inc EDIT
$3.53
▼ -1.12%
($-0.04)
Open
$3.58
Prev Close
$3.57
Day Range
$3.43 – $3.58
52W Range
$1.56 – $4.54
Market Cap
$349.53M
Beta
2.14
EPS (TTM)
$-1.22
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-02-03 |
| Shares Out. | 97,910,000 |
| Website | editasmedicine.com/ ↗ |
| Phone | 16174019000 |
Editas Medicine Inc is a publicly traded company under the ticker symbol EDIT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
20 analysts (2026-05-01)
📰 Latest News for EDIT
Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday
Which stocks are moving before the opening bell on Tuesday?
Editas Medicine Prices $125M Public Offering Of 55.6M Shares And Warrants At $2.25 Each
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Editas Medicine Launches Public Stock Offering to Raise Capital
Editas Reports Cholesterol-Lowering Results for Experimental Gene Therapy
Editas Medicine Reports New Preclinical Data Demonstrating Progress of Edit-401 as Potential Treatment for Hyperlipidemia